1. Home
  2. WGS

WGS

GeneDx Holdings Corp.

Logo GeneDx Holdings Corp.

Technology

Retail: Computer Software & Peripheral Equipment

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.

Founded: 2017 Country:
United States
United States
Employees: N/A City: STAMFORD
Market Cap: 291.5M IPO Year: N/A
Target Price: $11.00 AVG Volume (30 days): 220.3K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.23 EPS Growth: N/A
52 Week Low/High: $1.16 - $12.24 Next Earning Date: 04-29-2024
Revenue: $202,566,000 Revenue Growth: -13.69%
Revenue Growth (this year): 12.73% Revenue Growth (next year): 17.41%

Share on Social Networks: